Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAXELIS (V419) with Meningococcal C Vaccines in Infants
NCT01553279Phase 3Completed
- Sponsor
- MCM Vaccine
- Start
- Mar 2012
- Primary completion
- Sep 2013
- Modality
- Split/Subunit Vaccines
01
Overview
Phase 3, randomised, open-label trial of DTaP-IPV-Hep B-PRP-T vaccine in diphtheria, Tetanus, pertussis and 4 more, sponsored by MCM Vaccine. Started Mar 2012; status: completed.
02
Drugs
DTaP-IPV-Hep B-PRP-T vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01553279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553279.